title: Diabetic plasticity of non-adrenergic non-cholinergic and P2X-mediated rat bladder contractions.
abstract: We investigated the plasticity effects of diabetes mellitus and diuresis on the non-adrenergic non-cholinergic (NANC) and purinergic (P2X-type) contractile responses in longitudinal rat bladder strips. Female Sprague-Dawley rats received streptozotocin to induce diabetes, or sucrose in water to induce diuresis as a control condition for polyuria. Experiments were carried out at four weeks after treatments, using bladders from non-treated rats as control. Urinary bladder strips were electrically stimulated throughout the experiments to generate neurally evoked contractions (NEC). In all cases, P2X-mediated purinergic contractions were evaluated at the beginning and end of the stimulations with α,β-methylene-adenosine triphosphate (α,βMeATP). The NANC responses were assessed by using two independent protocols. First, cholinergic receptors were activated with carbachol (CCh), followed by inhibition of the muscarinic component with atropine. In the second protocol, the application order for CCh and atropine was reversed. The NANC response, unmasked with the application of atropine, and the P2X purinergic contractions were analyzed. NANC contractions in diabetic bladder strips are more resistant to the desensitizing effects caused by activation of cholinergic receptors. In early stages of experimental diabetes, NANC responses in diabetic strips are less sensitive to functional inhibition mediated by the cholinergic activation. However, P2X-mediated purinergic contractions are more sensitive to desensitization in diabetic or diuretic bladders. For instance preventing muscarinic receptor activation with atropine does not counteract the desensitization of purinergic contractions in either diabetic or diuretic strips. We suggest that diabetes may induce a plasticity of the NANC and P2X-mediated bladder contractile responses. The first one may be associated with diabetic neuropathic damage to bladder nerves, while impaired P2X purinergic contractions might be associated with detrusor hypertrophy observed in diabetic and diuretic strips.
authors.affiliation: Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA. amunoz@tmhs.org
authors.forename: Alvaro
authors.initials: A
authors.lastname: Munoz
authors.forename: Timothy B
authors.initials: TB
authors.lastname: Boone
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Smith
authors.forename: George T
authors.initials: GT
authors.lastname: Somogyi
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D003920:Diabetes Mellitus / Q000139:chemically induced; D004195:Disease Models, Animal; D004231:Diuresis / Q000187:drug effects; D004558:Electric Stimulation / Q000379:methods; D005260:Female; D009119:Muscle Contraction / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D058911:Purinergic P2X Receptor Agonists / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011950:Receptors, Cholinergic / Q000378:metabolism*; D058469:Receptors, Purinergic P2X / Q000378:metabolism*; D001743:Urinary Bladder / Q000294:innervation / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D058911:Purinergic P2X Receptor Agonists; D011950:Receptors, Cholinergic; D058469:Receptors, Purinergic P2X; D000255:Adenosine Triphosphate
references.citation: J Physiol. 1970 Oct;210(3):761-83
references.pmid: 5499824
references.citation: Nat Rev Neurol. 2011 Sep 13;7(10):573-83
references.pmid: 21912405
references.citation: Eur Urol. 2010 Jun;57(6):1087-92
references.pmid: 20022422
references.citation: Brain Res Bull. 2008 Dec 16;77(6):420-6
references.pmid: 18755252
references.citation: J Urol. 2013 Mar;189(3):1130-6
references.pmid: 22999997
references.citation: J Pharmacol Exp Ther. 1993 Oct;267(1):134-9
references.pmid: 7901388
references.citation: Handb Exp Pharmacol. 2011;(202):485-526
references.pmid: 21290240
references.citation: BMC Urol. 2010 May 24;10:10
references.pmid: 20497558
references.citation: IDrugs. 2010 Oct;13(10):713-22
references.pmid: 20878594
references.citation: Am J Physiol Renal Physiol. 2005 Jun;288(6):F1220-6
references.pmid: 15687244
references.citation: Nat Rev Neurosci. 2008 Jun;9(6):453-66
references.pmid: 18490916
references.citation: Vascul Pharmacol. 2006 Oct;45(4):221-6
references.pmid: 16891158
references.citation: J Neurol. 2008 Nov;255(11):1693-702
references.pmid: 18825430
references.citation: BJU Int. 2011 Jun;107(12):1988-93
references.pmid: 21087392
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):437-48
references.pmid: 18034230
references.citation: Neurosci Lett. 2007 Aug 9;423(1):1-5
references.pmid: 17630213
references.citation: Br J Pharmacol. 1998 Sep;125(2):241-6
references.pmid: 9786494
references.citation: Br J Pharmacol. 2006 Jul;148(5):565-78
references.pmid: 16751797
references.citation: J Physiol Pharmacol. 2012 Jun;63(3):209-16
references.pmid: 22791634
references.citation: Auton Autacoid Pharmacol. 2006 Jul;26(3):303-9
references.pmid: 16879496
references.citation: Neurochem Int. 2007 Jan;50(2):345-50
references.pmid: 17067723
references.citation: World J Urol. 1994;12(5):233-44
references.pmid: 7532513
references.citation: J Urol. 1995 Jun;153(6):2014-21
references.pmid: 7752386
references.citation: BJU Int. 2012 Oct;110(8 Pt B):E409-14
references.pmid: 22540742
references.citation: Neurochem Int. 2011 Feb;58(3):295-300
references.pmid: 21145365
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Sep;291(3):R837-43
references.pmid: 16513765
references.citation: J Urol. 1997 Nov;158(5):1973-7
references.pmid: 9334652
references.citation: J Physiol. 1996 Oct 1;496 ( Pt 1):245-54
references.pmid: 8910212
references.citation: J Urol. 2002 Jul;168(1):303-7
references.pmid: 12050561
references.citation: Acta Physiol Scand. 1988 Feb;132(2):233-9
references.pmid: 2465662
references.citation: Brain Res Bull. 2011 Aug 10;86(1-2):91-6
references.pmid: 21689735